Clinical Trial Update: Efficacy Study of Omalizumab in Cholinergic Urticaria [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy of omalizumab for cholinergic urticaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholinergic Urticaria

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Cholinergic Urticaria | Phase 2 | Status: COMPLETED